Philstar Life reports on FDA worries about unapproved weight loss drugs, including retatrutide, which is still in trials. Few details given, so check the source.
Recap by typeshit. Full story at Philstar Life.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A lighthearted panel chat with one real takeaway: lean muscle can account for 15 to 40% of the weight people lose on a GLP-1.
A team led by IBEC with IQAC-CSIC and the University of Barcelona reports the molecule reduced the Alzheimer's-linked protein in mouse studies.
Loading…